Innovation

Innovation has been the hallmark of Noble’s rich history. Two decades ago, when there were less than 100 EFTs, Noble created the first, self-rebalancing ETF investment portfolio system which is still in place today and has regularly outperformed the market. In 2018 Noble launched Channelchek; an investment community unlike any other.
Find out more

Research

Equity research is the foundation for making better investment decisions. Noble has been publishing small & microcap research for more than three decades. Since shifting to a company sponsored research (CRS) platform, Noble has become the leader in North America with all research available on Channelchek at no cost, for investors at any level.
Find out more

Since 1984

For close to 40 years, Noble has focused on small and microcap companies through equity research, trading, and investment and merchant banking activities. As a SEC-regulated, FINRA-licensed broker-dealer, Noble also offers issuers a full suite of services including fairness opinions, M&A management, valuations and stock buybacks.

Conferences

In 2005, Noble sponsored its first small & microcap investor conference – NobleCon. The conference grew in both size and content with the annual event featuring 100+ companies and keynote speakers such as Jeb Bush and Brian Mulroney (Canadian PM) and Steve Forbes. Today NobleCon is among the top-ranked equity conferences in North America.

Video Content

For close to 20 years, Noble has featured full HD video webcasts from its conferences; the first to do so in North America. Offering a broad range of video content through Channelchek was a natural transition. With a growing catalogue of more than 300 videos, investors can sit-in on c-suite dialogue and interact live through virtual roadshows.

follow @noblefinancial

Who we are what we stand for

We are a research-driven investment bank focused on small cap emerging growth companies in the healthcare, technology, media, transportation & logistics and natural resources sectors. That's what we are. Who we are is what makes us different.

Our people are talented, dedicated, experienced professionals who come together with a common cause; advising on long-term client-solutions by employing innovative, collaborative and responsive strategies. We're passionate and personable. We approach things from our clients' perspective.

We know that developing lasting relationships is reliant upon putting our clients' interests before ours. We understand the impact of our services. Insightful advisory and effective capital procurement can change lives. Empowering our clients to create employment, engineer technological and medical breakthroughs, producing products and services that lay the foundation for the future. For more than 30 years these have been our guiding principles. While much has changed over the three decades since we began, these core values and our reputation have not. Our clients must know what to expect from us. Then we can strive to exceed expectations.

Research Driven

Our investment decisions are driven by experienced analysts, conducting disciplined and in-depth rigorous research and analysis. By combining our experience with this comprehensive research process we are able to publish thoughtful fundamental research, generating actionable investment ideas for our institutional clients.

Scientific Advisory Board

Our Scientific Advisory Board is a strategic resource whose experience, relationships and knowledge are utilized throughout NOBLE Capital Markets to enhance all service offerings. Through the Advisory Board, we have access to world-class professionals for substantive advice regarding new discoveries, technologies, products, services and developments.

Management Team

Nico P. Pronk

CEO / President

Department:
Management

E: npronk@noblecapitalmarkets.com
T: (561) 998-5476
VCard: Nico P. Pronk

Mr. Pronk joined NOBLE Capital Markets in 1988 as Chief Operating Officer. In 1995, he became owner. Mr. Pronk began his career in Europe in 1986 on the European Options Exchange (EOE). Mr. Pronk has over 25 years of experience working with IPOs, Secondary Offerings, Private Placements and Mergers and Acquisitions. During his career he has served as Director or Advisor to numerous privately held and publicly traded companies. Mr. Pronk is a graduate of the Netherlands Institute of Banking and Finance, and holds various FINRA licenses. Mr. Pronk is the current Chairman, and principal owner of Privaira, a Boca Raton based private aviation company.

Nico P. Pronk, CEO / President

Mark Pinvidic

Managing Partner

Department:
Management

E: mpinvidic@noblecapitalmarkets.com
T: (561) 994-5742
VCard: Mark Pinvidic

Mr. Pinvidic joined NOBLE Capital Markets in 2002 bringing more than 25 years of senior management experience in corporate communications, marketing, sales and product development across several business sectors including oil & gas, healthcare / biotechnology, retail and consumer goods manufacturing. Throughout his career he has co-founded two public companies and created a consumer products company that, in 1999, was recognized by Women's Wear Daily as developing the most innovative and successful product launch of that year. Mr. Pinvidic has also been recognized by organizations such as the International Association of Business Communicators (IABC), the International Package Design Awards (IPDA), the Design Council of Canada, and the Toronto Art Director's Association for his work on annual reports, corporate identity programs, packaging design and consumer advertising. Mr. Pinvidic is responsible for all aspects of corporate identity, marketing and the management of the various conferences sponsored by NOBLE Capital Markets.

Mark Pinvidic, Managing Partner

Michael Kupinski

Director of Research, Senior Media & Entertainment Analyst

Department:
Management
Media and Entertainment

E: mkupinski@noblecapitalmarkets.com
T: (561) 994-5734
VCard: Michael Kupinski

Michael Kupinski joined Noble Financial in 2007 as director of research and Media & Entertainment senior research analyst. Before joining the company, he was the vice president and Media & Entertainment analyst for A.G. Edwards for twenty-three years. He is a member of the National Cable Television Society Foundation and the National Association of Broadcasters. He was a columnist for the Pulse of Radio, a broadcast radio trade publication, and a trustee of the National Television Academy. The Wall Street Journal selected Mr. Kupinski as a 'Best on the Street' All-Star Analyst in 1996, 1997, 1999, 2001, 2003, and in 2004 for his stock picking skills. Mr. Kupinski is widely quoted in national publications such as USA Today, The Wall Street Journal, and The New York Times, and is a frequent guest on cable news networks CNBC, CNN, and Bloomberg TV.

Michael Kupinski, Director of Research, Senior Media & Entertainment Analyst

Nathan Cali

Managing Director, Head of Healthcare Investment and Merchant Banking

Department:
Investment Banking
Healthcare

E: ncali@noblelsp.com
T: (561) 994-5723
VCard: Nathan Cali

Nathan Cali has more than 14 years of combined healthcare, biotechnology and pharmaceutical experience. Mr. Cali was previously a sell-side analyst for 9 years with expertise and publications cover many areas of biotechnology, specialty pharmaceuticals (branded and generics), medical devices, and regenerative medicine. He has been quoted in most business journals including Reuters, BioMed Reports and the Washington Business Journal. Mr Cali is the co-founder of Variant Pharmaceuticals an early stage biotechnology company advancing orphan drugs for the treatment of renal diseases. He is currently a Committee Member at the Moffitt Cancer Center for Commercialization and a member of the Development Board of Palm Beach County. Mr. Cali started his career in healthcare at Andrx Corporation, a biotechnology and specialty pharmaceuticals company known for its expertise in the development of controlled-release drugs. Mr. Cali was a corporate manager dealing in finance, state taxation, corporate governance, patents, drug distribution and business development for the biotechnology firm. Andrx was purchased by Watson Pharmaceuticals in 2006 for $2.0 billion in cash. Prior to joining NOBLE, Mr. Cali gained investment experience as a portfolio account analyst/manager at Franklin Templeton Investments. Mr. Cali holds a B.S. in Finance from The Florida State University and an M.B.A. in Finance from Nova Southeastern University. Nathan also currently holds series 7, 79, 86, and 87 FINRA designations.

Nathan Cali, Managing Director, Head of Healthcare Investment and Merchant Banking

David Lean

Head Trader, Director of Institutional Sales and Trading - Chief Compliance Officer

Department:
Trader

E: dlean@noblecapitalmarkets.com
T: (561) 994-5737

David joined Noble Capital Markets in 2017 and brings over 20 years of Wall Street experience with an emphasis in US Equities Trading. Before joining the company, David was a Partner at Variant Trading Institutional Group and a Senior Sales Trader at both J.Byrne and Company and Avalon Research Group. He started his career at Prudential Securities. David is FINRA licensed with Series 7, 24, 55, 63 and 65 and received his Bachelor of Arts from Muhlenberg College.

David Lean, Head Trader, Director of Institutional Sales and Trading - Chief Compliance Officer